Inhibitor of dihydroorotate dehydrogenase, the fourth enzyme in the de novo pyrimidine biosynthetic pathway; depresses lymphocyte proliferation. Prepn: D. P. Hesson, EP 133244; idem, US 4680299 (1985, 1987 both to DuPont). Mechanisms of action: T. L. Forrest et al., Transplantation 58, 920 (1994). Clinical pharmacokinetics: M. de Forni et al., Eur. J. Cancer 29A, 983 (1993). Symposium on pharmacology, toxicology: Transplant. Proc. 25, Suppl. 2, 1-83 (1993). Review of development and clinical experience: L. Makowka et al., Immunol. Rev. 136, 51-70 (1993).
Immunosuppressant.
Immunosuppressant